Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph early_phase_1
1
25%
Ph phase_1
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completedearly_phase_1

Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults

NCT06600607
terminatedphase_3

Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery

NCT04517110
completedphase_2

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

NCT02215252
completedphase_1

Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints

NCT02349607

Clinical Trials (4)

Showing 4 of 4 trials
NCT06600607Early Phase 1

Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults

Completed
NCT04517110Phase 3

Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery

Terminated
NCT02215252Phase 2

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Completed
NCT02349607Phase 1

Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4